1. Home
  2. BAH vs ALKS Comparison

BAH vs ALKS Comparison

Compare BAH & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Booz Allen Hamilton Holding Corporation

BAH

Booz Allen Hamilton Holding Corporation

HOLD

Current Price

$78.82

Market Cap

9.6B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$44.48

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAH
ALKS
Founded
1914
1987
Country
United States
Ireland
Employees
31500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.7B
IPO Year
2010
2012

Fundamental Metrics

Financial Performance
Metric
BAH
ALKS
Price
$78.82
$44.48
Analyst Decision
Hold
Buy
Analyst Count
15
20
Target Price
★ $84.38
$56.21
AVG Volume (30 Days)
1.5M
★ 2.0M
Earning Date
10-23-2026
11-03-2026
Dividend Yield
★ 3.15%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.63
N/A
Revenue
★ $11,217,000,000.00
$1,475,899,000.00
Revenue This Year
$1.83
$23.54
Revenue Next Year
$4.66
$6.53
P/E Ratio
$45.85
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$59.50
$27.00
52 Week High
$109.10
$55.67

Technical Indicators

Market Signals
Indicator
BAH
ALKS
Relative Strength Index (RSI) 65.33 58.24
Support Level $75.15 $39.41
Resistance Level $80.95 $47.40
Average True Range (ATR) 2.41 1.46
MACD 0.77 0.68
Stochastic Oscillator 95.87 87.62

Price Performance

Historical Comparison
BAH
ALKS

About BAH Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: